scholarly article | Q13442814 |
P50 | author | Amy Ramsey | Q61089764 |
Damian M Cummings | Q64663855 | ||
Marc Caron | Q64858849 | ||
P2093 | author name string | Carlos Cepeda | |
Michael S Levine | |||
Véronique M André | |||
Nanping Wu | |||
Shilpa P Rao | |||
Emily L Jocoy | |||
P2860 | cites work | Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit | Q24309045 |
Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice | Q28507147 | ||
Mice with reduced NMDA receptor expression display behaviors related to schizophrenia | Q28510751 | ||
Modulatory actions of dopamine on NMDA receptor-mediated responses are reduced in D1A-deficient mutant mice | Q28510955 | ||
Fast NMDA receptor-mediated synaptic currents in neurons from mice lacking the epsilon2 (NR2B) subunit | Q28513031 | ||
Modulation of D2R-NR2B interactions in response to cocaine | Q28566108 | ||
Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32 | Q28570233 | ||
Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking | Q28570291 | ||
Developmental and regional expression in the rat brain and functional properties of four NMDA receptors | Q28570615 | ||
Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor | Q28577705 | ||
Reduced spontaneous activity of mice defective in the epsilon 4 subunit of the NMDA receptor channel | Q28585536 | ||
D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons | Q29619181 | ||
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways | Q29619779 | ||
Dopamine signals for reward value and risk: basic and recent data | Q33563207 | ||
NMDA receptor hypofunction model of schizophrenia | Q33813143 | ||
Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice | Q34098463 | ||
Dopamine D2 receptor overexpression alters behavior and physiology in Drd2-EGFP mice | Q34780457 | ||
Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin | Q35013054 | ||
Dichotomous anatomical properties of adult striatal medium spiny neurons | Q35607269 | ||
Oligomeric assembly of dopamine D1 and glutamate NMDA receptors: molecular mechanisms and functional implications | Q35928471 | ||
Direct interactions between NMDA and D1 receptors: a tale of tails | Q35928476 | ||
NMDA receptor function: subunit composition versus spatial distribution | Q36544668 | ||
Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines | Q36588914 | ||
Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated | Q36599964 | ||
Impaired discrimination learning in mice lacking the NMDA receptor NR2A subunit. | Q36617546 | ||
NR1 knockdown mice as a representative model of the glutamate hypothesis of schizophrenia. | Q37714963 | ||
Dopamine and glutamate in Huntington's disease: A balancing act. | Q37734563 | ||
Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles. | Q40471504 | ||
Dopamine receptors regulate NMDA receptor surface expression in prefrontal cortex neurons | Q41838215 | ||
Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32. | Q42455499 | ||
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 | ||
Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice | Q42680585 | ||
The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice | Q42703159 | ||
Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids. | Q43187066 | ||
Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane. | Q43683702 | ||
Subcellular segregation of distinct heteromeric NMDA glutamate receptors in the striatum | Q44418532 | ||
Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons | Q44463501 | ||
Dopaminergic modulation of prefrontal cortical input to nucleus accumbens neurons in vivo. | Q44755321 | ||
Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms. | Q44919590 | ||
In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease. | Q45293042 | ||
Changes in expression of N-methyl-D-aspartate receptor subunits occur early in the R6/2 mouse model of Huntington's disease | Q45301002 | ||
Both NR2A and NR2B subunits of the NMDA receptor are critical for long-term potentiation and long-term depression in the lateral amygdala of horizontal slices of adult mice. | Q45993900 | ||
Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons in slices: contribution of calcium conductances | Q46110140 | ||
Neuromodulatory actions of dopamine on synaptically-evoked neostriatal responses in slices | Q46133563 | ||
NR2A-containing NMDA receptors depress glutamatergic synaptic transmission and evoked-dopamine release in the mouse striatum | Q46550073 | ||
NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways | Q46912173 | ||
Modulation by dopamine D1-like receptors of synaptic transmission and NMDA receptors in rat nucleus accumbens is attenuated by the protein kinase C inhibitor Ro 32-0432. | Q48226403 | ||
Expression of NMDA glutamate receptor subunit mRNAs in neurochemically identified projection and interneurons in the striatum of the rat. | Q48304457 | ||
Cyclic adenosine monophosphate-independent tyrosine phosphorylation of NR2B mediates cocaine-induced extracellular signal-regulated kinase activation. | Q48313759 | ||
A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor. | Q48329693 | ||
Contribution of NR2A and NR2B NMDA subunits to bidirectional synaptic plasticity in the hippocampus in vivo | Q48402794 | ||
Evidence for a tetrameric structure of recombinant NMDA receptors. | Q48487196 | ||
Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum | Q48657980 | ||
NR2A subunit expression shortens NMDA receptor synaptic currents in developing neocortex. | Q48757604 | ||
NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. | Q54168901 | ||
Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity | Q63256021 | ||
Cellular and molecular characterization of Ca2+ currents in acutely isolated, adult rat neostriatal neurons | Q72816561 | ||
P921 | main subject | dopamine | Q170304 |
striatum | Q1319792 | ||
P304 | page(s) | 28 | |
P577 | publication date | 2011-05-11 | |
P1433 | published in | Frontiers in Systems Neuroscience | Q15816495 |
P1476 | title | Dissecting the contribution of individual receptor subunits to the enhancement of N-methyl-d-aspartate currents by dopamine D1 receptor activation in striatum | |
P478 | volume | 5 |
Q40182651 | D1/NMDA receptors and concurrent methamphetamine+ HIV-1 Tat neurotoxicity |
Q34628184 | D1R/GluN1 complexes in the striatum integrate dopamine and glutamate signalling to control synaptic plasticity and cocaine-induced responses |
Q39062836 | Delta Opioid Receptors: Learning and Motivation |
Q41317144 | Disruption of subcellular Arc/Arg 3.1 mRNA expression in striatal efferent neurons following partial monoamine loss induced by methamphetamine |
Q46348695 | Dopamine-NMDA receptor interactions: twenty years later |
Q35282100 | Dopaminergic modulation of synaptic transmission in cortex and striatum |
Q39041217 | Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation |
Q36756257 | Frontal cortical synaptic communication is abnormal in Disc1 genetic mouse models of schizophrenia |
Q40789803 | GluN2A and GluN2B NMDA receptor subunits differentially modulate striatal output pathways and contribute to levodopa-induced abnormal involuntary movements in dyskinetic rats |
Q35286098 | Huntington's Disease and Striatal Signaling. |
Q36775271 | Impaired hippocampus-dependent and facilitated striatum-dependent behaviors in mice lacking the δ opioid receptor |
Q51740015 | In Vitro and In Vivo Identification of Novel Positive Allosteric Modulators of the Human Dopamine D2 and D3 Receptor. |
Q52676144 | Inhibition of phosphodiesterases as a strategy to achieve neuroprotection in Huntington's disease. |
Q38358456 | Modulation of excitatory neurotransmission by neuronal/glial signalling molecules: interplay between purinergic and glutamatergic systems |
Q26830654 | Modulation of the glutamatergic transmission by Dopamine: a focus on Parkinson, Huntington and Addiction diseases |
Q41927894 | N-methyl-D-aspartate (NMDA) receptor composition modulates dendritic spine morphology in striatal medium spiny neurons. |
Q50023605 | Opioid and Psychostimulant Plasticity: Targeting Overlap in Nucleus Accumbens Glutamate Signaling |
Q37930190 | Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function. |
Q28394979 | Review: Modulation of striatal neuron activity by cyclic nucleotide signaling and phosphodiesterase inhibition |
Q48329427 | Selective remodeling of glutamatergic transmission to striatal cholinergic interneurons after dopamine depletion |
Q36626038 | Striatal development involves a switch in gene expression networks, followed by a myelination event: implications for neuropsychiatric disease |
Q30418618 | Sustained N-methyl-d-aspartate receptor hypofunction remodels the dopamine system and impairs phasic signaling. |
Q38852012 | The Regulation of GluN2A by Endogenous and Exogenous Regulators in the Central Nervous System |
Search more.